Hyderabad-based Nucelion Therapeutics and Bengaluru's Pandorum Technologies have partnered to advance two PRIP-backed ophthalmology projects targeting advanced keratopathy and wet age-related macular degeneration. The projects have a combined planned outlay of Rs. 16.97 crore, including up to Rs. 8 crore in PRIP funding. Hyderabad: Hyderabad-based Nucelion Therapeutics, a subsidiary of Bharat Biotech, and Bengaluru's Pandorum Technologies have announced a manufacturing partnership to advance two Promotion of Research and Innovation in Pharma-MedTech (PRIP)-backed.